Impulse control disorder (ICD) is a major non-motor complication of Parkinson's disease (PD) with often devastating consequences for patients' quality of life. In this study, we aimed to characterize the phenotype of impulsivity in PD and its neuroanatomical correlates. Methods: Thirty-seven PD patients (15 patients with ICD, 22 patients without ICD) and 36 healthy controls underwent a neuropsychological battery. The test battery consisted of anxiety and depression scales, self-report measures of impulsivity (Barratt scale and UPPS-P), behavioral measures of impulsive action (Go/No-Go task, Stop signal task) and impulsive choice (Delay discounting, Iowa gambling task), and measures of cognitive abilities (working memory, attention, executive function). Patients and controls underwent structural MRI scanning. Results: Patients with ICD had significantly higher levels of self-reported impulsivity (Barratt scale and Lack of perseverance from UPPS-P) in comparison with healthy controls and non-impulsive PD patients, but they performed similarly in behavioral tasks, except for the Iowa gambling task. In this task, patients with ICD made significantly less risky decisions than patients without ICD and healthy controls. Patients without ICD did not differ from healthy controls in self-reported impulsivity or behavioral measurements. Both patient groups were more anxious and depressive than healthy controls. MRI scanning revealed structural differences in cortical areas related to impulse control in both patient groups. Patients without ICD had lower volumes and cortical thickness of bilateral inferior frontal gyrus. Patients with ICD had higher volumes of right caudal anterior cingulate and rostral middle frontal cortex. Conclusions: Despite the presence of ICD as confirmed by both clinical follow-up and self-reported impulsivity scales and supported by structural differences in various neural nodes related to inhibitory control and reward processing, patients with ICD performed no worse than healthy controls in various behavioral tasks previously hypothesized as robust impulsivity measures. These results call for caution against impetuous interpretation of behavioral tests, since various factors may and will influence the ultimate outcomes, be it the lack of sensitivity in specific, limited ICD subtypes, excessive caution of ICD patients during testing due to previous negative experience rendering simplistic tasks insufficient, or other, as of now unknown aspects, calling for further research.

1st Department of Neurology Faculty of Medicine Masaryk University and St Anne's University Hospital Brno Czechia

Behavioral and Social Neuroscience Research Group CEITEC Central European Institute of Technology Masaryk University Brno Czechia

Department of Neurology School of Medicine University of Minnesota Minneapolis MN United States

Department of Psychiatry Faculty of Medicine Masaryk University Brno and University Hospital Brno Czechia

Faculty of Medicine Institute of Psychology and Psychosomatics Masaryk University Brno and University Hospital Brno Czechia

Zobrazit více v PubMed

Evans AH, Katzenschlager R, Paviour D, O'Sullivan JD, Appel S, Lawrence AD, et al. . Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome. Mov Disord. (2004) 19:397–405. 10.1002/mds.20045 PubMed DOI

Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. . Impulse Control Disorders in Parkinson Disease. Arch Neurol. (2010) 67:589–95. 10.1001/archneurol.2010.65 PubMed DOI

Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson's disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord. (2007) 22:1757–63. 10.1002/mds.21611 PubMed DOI

Evans AH, Strafella AP, Weintraub D, Stacy M. Impulsive and compulsive behaviors in Parkinson's disease. Mov Disord. (2009) 24:1561–70. 10.1002/mds.22505 PubMed DOI

Leeman RF, Potenza MN. Impulse control disorders in Parkinson's disease: clinical characteristics and implications. Neuropsychiatry. (2011) 1:133–47. 10.2217/npy.11.11 PubMed DOI PMC

Linhartová P, Širuček J, Ejova A, Barteček R, Theiner P, Kašpárek T. Dimensions of impulsivity in healthy people, patients with borderline personality disorder, and patients with attention-deficit/hyperactivity disorder. J Atten Disord. (2019). 10.1017/S0033291719001892. [Epub ahead of print]. PubMed DOI

Bayard S, Joly E, Ghisletta P, Rossignol A, Herades Y, Geny C, et al. . A multidimensional approach to impulsivity in Parkinson's disease: measurement and structural invariance of the UPPS Impulsive Behaviour Scale. Psychol Med. (2016) 46:2931–1. 10.1017/S0033291716001586 PubMed DOI

Bódi N, Kéri S, Nagy H, Moustafa A, Myers CE, Daw N, et al. Reward-learning and the novelty-seeking personality: a between-and within-subjects study of the effects of dopamine agonists on young parkinsons patients. Brain. (2009) 132:2385–95. 10.1093/brain/awp094 PubMed DOI PMC

Voon V, Sohr M, Lang AE, Potenza MN, Siderowf AD, Whetteckey J, et al. . Impulse control disorders in parkinson disease: a multicenter case-control study. Ann Neurol. (2011) 69:986–96. 10.1002/ana.22356 PubMed DOI

Bentivoglio AR, Baldonero E, Ricciardi L, De Nigris F, Daniele A. Neuropsychological features of patients with Parkinson's disease and impulse control disorders. Neurol Sci. (2013) 34:1207–13. 10.1007/s10072-012-1224-5 PubMed DOI

Djamshidian A, Jha A, O'Sullivan SS, Silveira-Moriyama L, Jacobson C, Brown P, et al. . Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease. Mov Disord. (2010) 25:2203–10. 10.1002/mds.23247 PubMed DOI PMC

Evans AH, Lawrence AD, Potts J, MacGregor L, Katzenschlager R, Shaw K, et al. . Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. J Neurol Neurosurg Psychiatry. (2006) 77:317–21. 10.1136/jnnp.2005.065417 PubMed DOI PMC

Voon V, Thomsen T, Miyasaki JM, de Souza M, Shafro A, Fox SH, et al. . Factors associated with dopaminergic drug–related pathological gambling in Parkinson Disease. Arch Neurol. (2007) 64:212. 10.1001/archneur.64.2.212 PubMed DOI

Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KHD, Duda JE, et al. Dopamine agonist use is associated with impulse control disorders in Parkinson's Disease NIH public access. Arch Neurol. (2006) 63:969–73. 10.1001/archneur.63.7.969 PubMed DOI PMC

Brand M, Labudda K, Kalbe E. Decision-making impairments in patients with Parkinson's disease. Behav Neurol. (2004) 15:77–85. 10.1155/2004/578354 PubMed DOI PMC

Kobayakawa M, Tsuruya N, Kawamura M. Sensitivity to reward and punishment in Parkinson's disease: An analysis of behavioral patterns using a modified version of the Iowa gambling task. Parkinsonism Relat Disord. (2010) 16:453–7. 10.1016/j.parkreldis.2010.04.011 PubMed DOI

Mimura M, Oeda R, Kawamura M. Impaired decision-making in Parkinson's disease. Park Relat Disord. (2006) 12:169–75. 10.1016/j.parkreldis.2005.12.003 PubMed DOI

Pagonabarraga J, García-Sánchez C, Llebaria G, Pascual-Sedano B, Gironell A, Kulisevsky J. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord. (2007) 22:1430–5. 10.1002/mds.21457 PubMed DOI

Perretta JG, Pari G, Beninger RJ. Effects of Parkinson disease on two putative nondeclarative learning tasks: probabilistic classification and gambling. Cogn Behav Neurol. (2005) 18:185–92. 10.1097/01.wnn.0000187939.81541.1d PubMed DOI

Gescheidt T, Czekóová K, Urbánek T, Mareček R, Mikl M, Kubíková R, et al. . Iowa Gambling Task in patients with early-onset Parkinson's disease: strategy analysis. Neurol Sci. (2012) 33:1329–35. 10.1007/s10072-012-1086-x PubMed DOI

Ibarretxe-Bilbao N, Junque C, Tolosa E, Marti MJ, Valldeoriola F, Bargallo N, et al. . Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease. Eur J Neurosci. (2009) 30:1162–71. 10.1111/j.1460-9568.2009.06892.x PubMed DOI

Mapelli D, Di Rosa E, Cavalletti M, Schiff S, Tamburin S. Decision and dopaminergic system: an ERPs study of Iowa gambling task in Parkinson's disease. Front Psychol. (2014) 5:684. 10.3389/fpsyg.2014.00684 PubMed DOI PMC

Kobayakawa M, Tsuruya N, Kawamura M. Decision-making performance in Parkinson's disease correlates with lateral orbitofrontal volume. J Neurol Sci. (2017) 372:232–8. 10.1016/j.jns.2016.11.046 PubMed DOI

Housden CR, O'Sullivan SS, Joyce EM, Lees AJ, Roiser JP. Intact reward learning but elevated delay discounting in Parkinson's disease patients with impulsive-compulsive spectrum behaviors. Neuropsychopharmacology. (2010) 35:2155–64. 10.1038/npp.2010.84 PubMed DOI PMC

Rossi M, Gerschcovich ER, De Achaval D, Perez-Lloret S, Cerquetti D, Cammarota A, et al. . Decision-making in Parkinson's disease patients with and without pathological gambling. Eur J Neurol. (2010) 17:97–102. 10.1111/j.1468-1331.2009.02792.x PubMed DOI

Djamshidian A, O'Sullivan SS, Sanotsky Y, Sharman S, Matviyenko Y, Foltynie T, et al. . Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions? Mov Disord. (2012) 27:1137–45. 10.1002/mds.25105 PubMed DOI PMC

Voon V, Gao J, Brezing C, Symmonds M, Ekanayake V, Fernandez H, et al. . Dopamine agonists and risk: impulse control disorders in Parkinson's; disease. Brain. (2011) 134:1438–46. 10.1093/brain/awr080 PubMed DOI PMC

Voon V, Reynolds B, Brezing C, Gallea C, Skaljic M, Ekanayake V, et al. . Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology. (2010) 207:645–59. 10.1007/s00213-009-1697-y PubMed DOI PMC

Biars JW, Johnson NL, Nespeca M, Busch RM, Kubu CS, Floden DP. Iowa gambling task performance in parkinson disease patients with impulse control disorders. Arch Clin Neuropsychol. (2019) 34:310–8. 10.1093/arclin/acy036 PubMed DOI PMC

Poletti M, Frosini D, Lucetti C, Dotto Del P, Ceravolo R, Bonuccelli U. Decision making in de novo Parkinson's disease. Mov Disord. (2010) 25:1432–6. 10.1002/mds.23098 PubMed DOI

Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R. Motivation, reward, and Parkinson's disease: Influence of dopatherapy. Neuropsychologia. (2002) 40:2257–67. 10.1016/S0028-3932(02)00108-2 PubMed DOI

Euteneuer F, Schaefer F, Stuermer R, Boucsein W, Timmermann L, Barbe MT, et al. . Dissociation of decision-making under ambiguity and decision-making under risk in patients with Parkinson's disease: a neuropsychological and psychophysiological study. Neuropsychologia. (2009) 47:2882–90. 10.1016/j.neuropsychologia.2009.06.014 PubMed DOI

Martini A, Ellis SJ, Grange JA, Tamburin S, Dal Lago D, Vianello G, et al. . Risky decision-making and affective features of impulse control disorders in Parkinson's disease. J Neural Transm. (2018) 125:131–43. 10.1007/s00702-017-1807-7 PubMed DOI PMC

Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, et al. . Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Mov Disord. (2010) 25:1660–9. 10.1002/mds.23147 PubMed DOI PMC

Claassen DO, van den Wildenberg WPM, Ridderinkhof KR, Jessup CK, Harrison MB, Wooten GF, et al. . The risky business of dopamine agonists in Parkinson disease and impulse control disorders. Behav Neurosci. (2011) 125:492–500. 10.1037/a0023795 PubMed DOI PMC

Leplow B, Sepke M, Schönfeld R, Pohl J, Oelsner H, Latzko L, et al. . Impaired learning of punishments in Parkinson's disease with and without impulse control disorder. J Neural Transm. (2017) 124:217–25. 10.1007/s00702-016-1648-9 PubMed DOI

Piray P, Zeighami Y, Bahrami F, Eissa AM, Hewedi DH, Moustafa AA. Impulse control disorders in Parkinson's disease are associated with dysfunction in stimulus valuation but not action valuation. J Neurosci. (2014) 34:7814–24. 10.1523/JNEUROSCI.4063-13.2014 PubMed DOI PMC

Gauggel S, Rieger M, Feghoff T-A. Inhibition of ongoing responses in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. (2004) 75:539–44. 10.1136/jnnp.2003.016469 PubMed DOI PMC

Obeso I, Wilkinson L, Casabona E, Bringas ML, Álvarez M, Álvarez L, et al. . Deficits in inhibitory control and conflict resolution on cognitive and motor tasks in Parkinson's disease. Exp Brain Res. (2011) 212:371–84. 10.1007/s00221-011-2736-6 PubMed DOI

Obeso I, Wilkinson L, Jahanshahi M. Levodopa medication does not influence motor inhibition or conflict resolution in a conditional stop-signal task in Parkinson's disease. Exp Brain Res. (2011) 213:435–45. 10.1007/s00221-011-2793-x PubMed DOI

Tolleson C, Turchan M, van Wouwe N, Isaacs D, Phibbs F, Wylie S. Parkinson's Disease subtypes show distinct tradeoffs between response initiation and inhibition latencies. J Int Neuropsychol Soc. (2017) 23:665–74. 10.1017/S1355617717000467 PubMed DOI

O'Callaghan C, Naismith SL, Hodges JR, Lewis SJG, Hornberger M. Fronto-striatal atrophy correlates of inhibitory dysfunction in parkinson's disease versus behavioural variant frontotemporal dementia. Cortex. (2013) 49:1833–43. 10.1016/j.cortex.2012.12.003 PubMed DOI

Claassen DO, van den Wildenberg WPM, Harrison MB, van Wouwe NC, Kanoff K, Neimat JS, et al. . Proficient motor impulse control in Parkinson disease patients with impulsive and compulsive behaviors. Pharmacol Biochem Behav. (2015) 129:19–25. 10.1016/j.pbb.2014.11.017 PubMed DOI PMC

Manza P, Schwartz G, Masson M, Kann S, Volkow ND, Li CR, et al. . Levodopa improves response inhibition and enhances striatal activation in early-stage Parkinson's disease. Neurobiol Aging. (2018) 66:12–22. 10.1016/j.neurobiolaging.2018.02.003 PubMed DOI PMC

Baglio F, Blasi V, Falini A, Farina E, Mantovani F, Olivotto F, et al. . Functional brain changes in early Parkinson's disease during motor response and motor inhibition. Neurobiol Aging. (2011) 32:115–24. 10.1016/j.neurobiolaging.2008.12.009 PubMed DOI

Wylie SA, Claassen DO, Huizenga HM, Schewel KD, Ridderinkhof KR, Bashore TR, et al. Dopamine agonists and the suppression of impulsive motor actions in Parkinson's Disease. J Cogn Neurosci. (2012) 24:1709 10.1162/jocn_a_00241 PubMed DOI PMC

Biundo R, Weis L, Facchini S, Formento-Dojot P, Vallelunga A, Pilleri M, et al. . Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease. Mov Disord. (2015) 30:688–95. 10.1002/mds.26154 PubMed DOI

Pellicano C, Niccolini F, Wu K, O'Sullivan SS, Lawrence AD, Lees AJ, et al. . Morphometric changes in the reward system of Parkinson's disease patients with impulse control disorders. J Neurol. (2015) 262:2653–61. 10.1007/s00415-015-7892-3 PubMed DOI

Tessitore A, Santangelo G, De Micco R, Vitale C, Giordano A, Raimo S, et al. . Cortical thickness changes in patients with Parkinson's disease and impulse control disorders. Park Relat Disord. (2016) 24:119–25. 10.1016/j.parkreldis.2015.10.013 PubMed DOI

Yoo HS, Yun HJ, Chung SJ, Sunwoo MK, Lee JM, Sohn YH, et al. . Patterns of neuropsychological profile and cortical thinning in Parkinson's disease with punding. PLoS ONE. (2015) 10:e0134468. 10.1371/journal.pone.0134468 PubMed DOI PMC

Hammes J, Theis H, Giehl K, Hoenig MC, Greuel A, Tittgemeyer M, et al. . Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control. Brain. (2019) 142:733–43. 10.1093/brain/awz007 PubMed DOI

Cerasa A, Salsone M, Nigro S, Chiriaco C, Donzuso G, Bosco D, et al. . Cortical volume and folding abnormalities in Parkinson's disease patients with pathological gambling. Park Relat Disord. (2014) 20:1209–14. 10.1016/j.parkreldis.2014.09.001 PubMed DOI

Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. (1992) 55:181–4. 10.1136/jnnp.55.3.181 PubMed DOI PMC

Sheehan D, Lecrubier Y. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. (1998) 59:22–33. PubMed

Folstein MF, Folstein SE, Mchugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. (1975) 12:189–98. 10.1016/0022-3956(75)90026-6 PubMed DOI

Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology. (1967) 17:427. 10.1212/WNL.17.5.427 PubMed DOI

Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. (1995) 51:768–74. PubMed

Whiteside SP, Lynam DR. The Five Factor Model and impulsivity: using a structural model of personality to understand impulsivity. Personal Individ Diff. (2001) 30:669–89. 10.1016/S0191-8869(00)00064-7 DOI

Cyders MA, Smith GT. Mood-based rash action and its components: positive and negative urgency. Pers Individ Dif . (2007) 43:839–50. 10.1016/j.paid.2007.02.008 DOI

Linhartová P, Širuček J, Barteček R, Theiner P, Jerábková B, Daniela R. Czech versions of impulsivity self-report scales and their psychometric properties. Ces a Slov Psychiatr. (2017) 113:149–57.

Montgomery SA, Asberg M. A New depression scale designed to be sensitive to change. Br J Psychiatry. (1979) 134:382–9. 10.1192/bjp.134.4.382 PubMed DOI

Zung WWK. A rating instrument for anxiety disorders. Psychosomatics. (1971) 12:371–9. 10.1016/S0033-3182(71)71479-0 PubMed DOI

Reise SP, Moore TM, Sabb FW, Brown AK, London ED. The Barratt Impulsiveness Scale-11: reassessment of its structure in a community sample. Psychol Assess. (2013) 25:631–42. 10.1037/a0032161 PubMed DOI PMC

Steinberg L, Sharp C, Stanford MS, Tharp AT. New tricks for an old measure: the development of the barratt impulsiveness scale-brief (BIS-Brief). Psychol Assess. (2013) 25:216–26. 10.1037/t21455-000 PubMed DOI

Madden G, Bickel WK, Jacobs EA. Discounting of delayed rewards in opioid-dependent outpatients: exponential or hyperbolic discounting functions? Effects on infusion rate on the discriminative effects of opioids view project. Artic Exp Clin Psychopharmacol. (1999) 7:284–93. 10.1037/1064-1297.7.3.284 PubMed DOI

Myerson J, Green L, Warusawitharana M. Area under the curve as a measure of discounting. J Exp Anal Behav. (2001) 76:235–43. 10.1901/jeab.2001.76-235 PubMed DOI PMC

Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition. (1994) 50:7–15. 10.1016/0010-0277(94)90018-3 PubMed DOI

Odum AL. Delay discounting: I'm a k, You're a k. J Exp Anal Bahav. (2011) 96:427–39. 10.1901/jeab.2011.96-423 PubMed DOI PMC

Wechsler D. WAIS-3: Wechsler Adult Intelligence Scale: Administration and Scoring Manual. New York, NY: Psychological Corporation; (1997). 10.1037/t49755-000 DOI

Culbertson W, Zillmer E. Tower of London Drexel University. Toronto, ON: Multi-Health Systems; (2005).

Brickenkamp R, Schmidt-Atzert L, Liepmann D, Hoskovcová S CD. d2 Attention Test Revised. Prague: Hogrefe – Testcentrum; (2014).

Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. (2002) 33:341–55. 10.1016/S0896-6273(02)00569-X PubMed DOI

Isaias IU, Siri C, Cilia R, de Gaspari D, Pezzoli G, Antonini A. The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord. (2008) 23:411–5. 10.1002/mds.21872 PubMed DOI

Savvidou LG, Fagundo AB, Fernández-Aranda F, Granero R, Claes L, Mallorquí-Baqué N, et al. . Is gambling disorder associated with impulsivity traits measured by the UPPS-P and is this association moderated by sex and age? Compr Psychiatry. (2017) 72:106–13. 10.1016/j.comppsych.2016.10.005 PubMed DOI

Billieux J, Rochat L, Rebetez MML, Van der Linden M. Are all facets of impulsivity related to self-reported compulsive buying behavior? Pers Individ Dif . (2008) 44:1432–42. 10.1016/j.paid.2007.12.011 DOI

Williams AD, Grisham JR. Impulsivity, emotion regulation, and mindful attentional focus in compulsive buying. Cognit Ther Res. (2012) 36:451–7. 10.1007/s10608-011-9384-9 DOI

Zermatten A, Van der Linden M. Impulsivity in non-clinical persons with obsessive-compulsive symptoms. Pers Individ Dif . (2008) 44:1824–30. 10.1016/j.paid.2008.01.025 DOI

Claes L, Vandereycken W, Vertommen H. Impulsivity-related traits in eating disorder patients. Pers Individ Dif . (2005) 39:739–49. 10.1016/j.paid.2005.02.022 DOI

Riley EN, Combs JL, Jordan CE, Smith GT. Negative urgency and lack of perseverance: identification of differential pathways of onset and maintenance risk in the longitudinal prediction of nonsuicidal self-injury. Behav Ther. (2015) 46:439–48. 10.1016/j.beth.2015.03.002 PubMed DOI PMC

Cackowski S, Reitz A-C, Ende G, Kleindienst N, Bohus M, Schmahl C, et al. . Impact of stress on different components of impulsivity in borderline personality disorder. Psychol Med. (2014) 44:3329–40. 10.1017/S0033291714000427 PubMed DOI

Krause-Utz A, Cackowski S, Daffner S, Sobanski E, Plichta MM, Bohus M, et al. . Delay discounting and response disinhibition under acute experimental stress in women with borderline personality disorder and adult attention deficit hyperactivity disorder. Psychol Med. (2016) 46:3137–49. 10.1017/S0033291716001677 PubMed DOI

Nigg JT. Annual research review: on the relations among self-regulation, self-control, executive functioning, effortful control, cognitive control, impulsivity, risk-taking, and inhibition for developmental psychopathology. J Child Psychol Psychiatry Allied Discip. (2017) 58:361–83. 10.1111/jcpp.12675 PubMed DOI PMC

Imhoff S, Harris M, Weiser J, Reynolds B. Delay discounting by depressed and non-depressed adolescent smokers and non-smokers. Drug Alcohol Depend. (2014) 135:152–5. 10.1016/j.drugalcdep.2013.11.014 PubMed DOI

Patros CHG, Sweeney K, Mahone EM, Mostofsky SH, Rosch KS. Greater delay discounting among girls, but not boys, with ADHD correlates with cognitive control. Child Neuropsychol. (2018) 24:1026–46. 10.1080/09297049.2017.1359525 PubMed DOI PMC

Pulcu E, Trotter PD, Thomas EJ, McFarquhar M, Juhasz G, Sahakian BJ, et al. . Temporal discounting in major depressive disorder. Psychol Med. (2014) 44:1825–34. 10.1017/S0033291713002584 PubMed DOI PMC

Szuhany KL, MacKenzie D, Otto MW. The impact of depressed mood, working memory capacity, and priming on delay discounting. J Behav Ther Exp Psychiatry. (2018) 60:37–41. 10.1016/j.jbtep.2018.03.001 PubMed DOI PMC

Lin C-H, Chiu Y-C, Lee P-L, Hsieh J-C. Is deck B a disadvantageous deck in the Iowa gambling task? Behav Brain Funct. (2007) 3:16. 10.1186/1744-9081-3-16 PubMed DOI PMC

Gescheidt T, Mareček R, Mikl M, Czekóová K, Urbánek T, Vaníček J, et al. . Functional anatomy of outcome evaluation during Iowa Gambling Task performance in patients with Parkinson's disease: an fMRI study. Neurol Sci. (2013) 34:2159–66. 10.1007/s10072-013-1439-0 PubMed DOI

Fein G, Mcgillivray S, Finn P. Older adults make less advantageous decisions than younger adults: cognitive and psychological correlates. J Int Neuropsychol Soc. (2007) 13:480–9. 10.1017/S135561770707052X PubMed DOI PMC

Di Rosa E, Mapelli D, Arcara G, Amodio P, Tamburin S, Schiff S. Aging and risky decision-making: new ERP evidence from the Iowa gambling task. Neurosci Lett. (2017) 640:93–8. 10.1016/j.neulet.2017.01.021 PubMed DOI

Kable JW, Glimcher PW. The neural correlates of subjective value during intertemporal choice. Nat Neurosci. (2007) 10:1625–33. 10.1038/nn2007 PubMed DOI PMC

Nieuwenhuis S, Yeung N, van den Wildenberg W, Ridderinkhof KR. Electrophysiological correlates of anterior cingulate function in a go/no-go task: Effects of response conflict and trial type frequency. Cogn Affect Behav Neurosci. (2003) 3:17–26. 10.3758/CABN.3.1.17 PubMed DOI

Zheng D, Oka T, Bokura H, Yamaguchi S. The key locus of common response inhibition network for No-go and stop signals. J Cogn Neurosci. (2008) 20:1434–42. 10.1162/jocn.2008.20100 PubMed DOI

Simmonds DJ, Pekar JJ, Mostofsky SH. Meta-analysis of Go/No-go tasks demonstrating that fMRI activation associated with response inhibition is task-dependent. Neuropsychologia. (2008) 46:224–32. 10.1016/j.neuropsychologia.2007.07.015 PubMed DOI PMC

Steinbeis N, Bernhardt BC, Singer T. Impulse control and underlying functions of the left DLPFC mediate age-related and age-independent individual differences in strategic social behavior. Neuron. (2012) 73:1040–51. 10.1016/j.neuron.2011.12.027 PubMed DOI

Ricciardi L, Lambert C, De Micco R, Morgante F, Edwards M. Can we predict development of impulsive-compulsive behaviours in Parkinson's disease? J Neurol Neurosurg Psychiatry. (2018) 89:476–81. 10.1136/jnnp-2017-317007 PubMed DOI

Gerrits NJHM, van Loenhoud AC, van den Berg SF, Berendse HW, Foncke EMJ, Klein M, et al. . Cortical thickness, surface area and subcortical volume differentially contribute to cognitive heterogeneity in Parkinson's Disease. PLoS ONE. (2016) 11:e0148852. 10.1371/journal.pone.0148852 PubMed DOI PMC

Guimarães RP, Santos MCA, Dagher A, Campos LS, Azevedo P, Piovesana LG, et al. . Pattern of reduced functional connectivity and structural abnormalities in Parkinson's disease: an exploratory study. Front Neurol. (2017) 7:243. 10.3389/fneur.2016.00243 PubMed DOI PMC

Pan PL, Song W, Shang HF. Voxel-wise meta-analysis of gray matter abnormalities in idiopathic Parkinson's disease. Eur J Neurol. (2012) 19:199–206. 10.1111/j.1468-1331.2011.03474.x PubMed DOI

Filip P, Linhartová P, Hlavatá P, Šumec R, BalᎠM, Bareš M, et al. . Disruption of multiple distinctive neural networks associated with impulse control disorder in Parkinson's Disease. Front Hum Neurosci. (2018) 12:462. 10.3389/fnhum.2018.00462 PubMed DOI PMC

Different FreeSurfer versions might generate different statistical outcomes in case-control comparison studies